Travel Health Evidence

Praktično

Jesti u inozemstvu s celijakijom ili alergijom na hranu

Jezična barijera pretvara kontroliranu bolest u kockanje. Rješenje je većinom logističko, i vrijedi ga provesti prije nego što krenete.

Ažurirano 2 min čitanja 22 citati Snaga dokaza 3/5

Što vam daju pravila EU-a

Četrnaest glavnih alergena — uključujući žitarice koje sadrže gluten — mora se deklarirati u cijeloj EU, u pakiranoj hrani i u uslužnoj hrani. Pravila su dovoljno uniformna da putnik s celijakijom koji se kreće između država članica ima isti okvir označavanja, što je značajna i nedovoljno cijenjena prednost.

Ono što varira je provedba, kako uslužna hrana otkriva (usmeno, na jelovniku, u mapi), i kulturna upoznatost s tom bolešću. Neke zemlje imaju visoku javnu svijest o celijakiji; druge to tretiraju kao preferenciju.

Praktični sustav

  1. Nabavite karticu za prijevod na lokalnom jeziku, koja medicinski navodi stanje, imenuje što se mora izbjegavati i spominje zajedničke friteze i površine. Kartica ide u kuhinju; izgovorena rečenica ne ide.
  2. Naučite čitati popis sastojaka, a ne jezik. Alergeni su tipografski istaknuti u cijeloj EU, tako da ih možete pronaći bez čitanja ostatka.
  3. Rezervirajte smještaj s hladnjakom i kuhalom. To pretvara težak put u običan.
  4. Ponesite sigurnu hranu za putne dane. Zračne luke, stanice i duga putovanja su mjesta gdje ljudi zapnu.
  5. Pronađite lokalnu udrugu za celijakiju ili alergije. Većina europskih zemalja ima jednu, nekoliko objavljuje popise mjesta.
  6. Ponesite dovoljno lijekova — uključujući auto-injektore adrenalina gdje je relevantno — i nosite pismo s receptom.

Osiguranje i dokumentacija

Provjerite pokriva li putno osiguranje vaše stanje, i nosite dokumentaciju o bilo kojem lijeku u originalnom pakiranju s pismom s receptom. Unutar EU-a, Europska kartica zdravstvenog osiguranja pokriva nužno liječenje koje pruža država, što nije isto kao putno osiguranje i ne zamjenjuje ga.

Česta pitanja

Jesu li kartice za prijevod zapravo korisne?
Da, više nego govor. Kartica se može predati kuhinji, gdje se donose odluke.
Koje europske zemlje su najlakše s celijakijom?
Svijest varira više nego regulativa. Nacionalna društva za celijakiju su najbolji trenutni izvor, a ne bilo kakva generalizacija.
Mogu li prenijeti svoje lijekove preko granica?
Općenito da u originalnom pakiranju s pismom s receptom. Provjerite kontrolirane supstance posebno.
Što ako se inozemstvu izložim gluten?
Upravljajte simptomima i hidratacijom. Ne postoji liječenje za izloženost — pogledajte naš celijak site.

Reference

Svaka citacija u nastavku povezuje na izvorni recenzirani zapis na PubMedu ili putem DOI-a. Ništa ovdje nije zamjena za medicinski savjet.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Risk of anaphylaxis on commercial flights Turner PJ · Current opinion in allergy and clinical immunology · 2025 · Systematic review DOIPubMed 40643054Full text
  5. How Common Are Allergic Reactions During Commercial Flights? A Systematic Review and Meta-Analysis Turner PJ, Mamula J, Laktabi J, et al. · The journal of allergy and clinical immunology. In practice · 2023 · Meta-analysis DOIPubMed 37507067
  6. Skin care interventions in infants for preventing eczema and food allergy Kelleher MM, Cro S, Cornelius V, et al. · The Cochrane database of systematic reviews · 2021 · Meta-analysis DOIPubMed 33545739Full text
  7. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  8. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  9. Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review Versluis A, Knulst AC, Kruizinga AG, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015 · Systematic review DOIPubMed 24766413
  10. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community Muraro A, Agache I, Clark A, et al. · Allergy · 2014 · Clinical guideline DOIPubMed 24905609
  11. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  12. Effects of pregnancy and lactation prebiotics supplementation on infant allergic disease: A randomized controlled trial Palmer DJ, Cuthbert AR, Sullivan TR, et al. · The Journal of allergy and clinical immunology · 2025 · Randomised controlled trial DOIPubMed 39173718
  13. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial Kliewer KL, Gonsalves N, Dellon ES, et al. · The lancet. Gastroenterology & hepatology · 2023 · Randomised controlled trial DOIPubMed 36863390Full text
  14. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial Jackson DJ, Bacharier LB, Gergen PJ, et al. · Lancet (London, England) · 2022 · Randomised controlled trial DOIPubMed 35964610Full text
  15. Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper Pascal M, Chauhan J, Knol E, et al. · Allergy · 2025 · Review DOIPubMed 40503572Full text
  16. The epithelial barrier theory and its associated diseases Sun N, Ogulur I, Mitamura Y, et al. · Allergy · 2024 · Review DOIPubMed 39370939Full text
  17. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  18. The restaurant syndromes Settipane GA · New England and regional allergy proceedings · 1987 · Review DOIPubMed 3302666
  19. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  20. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  21. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  22. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 Shin YH, Hwang J, Kwon R, et al. · Allergy · 2023 · Journal article DOIPubMed 37431853Full text

Ova stranica je automatski prevedena s engleskog. Citati i brojevi su nepromijenjeni. Pročitajte engleski izvorni tekst ako išta zvuči čudno. Pročitajte engleski izvorni tekst